News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
670,399 Results
Type
Article (62948)
Company Profile (78)
Press Release (607364)
Multimedia
Podcasts (103)
Webinars (21)
Section
Business (175048)
Career Advice (2757)
Deals (32648)
Drug Delivery (118)
Drug Development (77403)
Employer Resources (154)
FDA (15216)
Job Trends (14001)
News (307454)
Policy (29394)
Tag
2027 Biotech Bay Standard (1)
2027 Pharm Country Standard (2)
Academia (2914)
Academic (2)
Accelerated approval (35)
Adcomms (28)
Allergies (145)
Alliances (43529)
ALS (170)
Alzheimer's disease (1611)
Antibody-drug conjugate (ADC) (298)
Approvals (15496)
Artificial intelligence (540)
Autoimmune disease (168)
Automation (41)
Bankruptcy (294)
Best Places to Work (10875)
BIOSECURE Act (16)
Biosimilars (180)
Biotechnology (57)
Bladder cancer (158)
Brain cancer (61)
Breast cancer (639)
Cancer (4789)
Cardiovascular disease (399)
Career advice (2355)
Career pathing (40)
CAR-T (290)
CDC (48)
Celiac Disease (2)
Cell therapy (772)
Cervical cancer (36)
Clinical research (66338)
Collaboration (1679)
Company closure (5)
Compensation (729)
Complete response letters (59)
COVID-19 (2693)
CRISPR (97)
C-suite (925)
Cystic fibrosis (145)
Data (6228)
Decentralized trials (2)
Denatured (41)
Depression (138)
Diabetes (475)
Diagnostics (6503)
Digital health (45)
Diversity (13)
Diversity, equity & inclusion (40)
Drug discovery (251)
Drug pricing (186)
Drug shortages (25)
Duchenne muscular dystrophy (216)
Earnings (63901)
Editorial (61)
Employer branding (18)
Employer resources (138)
Events (99355)
Executive appointments (1045)
FDA (18372)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (9)
Frontotemporal dementia (23)
Funding (1475)
Gene editing (206)
Generative AI (46)
Gene therapy (578)
GLP-1 (916)
Government (4738)
Grass and pollen (7)
Guidances (381)
Healthcare (18336)
HIV (60)
Huntington's disease (40)
IgA nephropathy (80)
Immunology and inflammation (228)
Immuno-oncology (59)
Indications (113)
Infectious disease (2960)
Inflammatory bowel disease (195)
Inflation Reduction Act (13)
Influenza (118)
Intellectual property (252)
Interviews (531)
IPO (14946)
IRA (47)
Job creations (3451)
Job search strategy (1953)
JPM (62)
Kidney cancer (18)
Labor market (76)
Layoffs (592)
Leadership (37)
Legal (6601)
Liver cancer (84)
Longevity (13)
Lung cancer (637)
Lymphoma (369)
Machine learning (40)
Management (54)
Manufacturing (758)
MASH (165)
Medical device (13069)
Medtech (13123)
Mergers & acquisitions (18823)
Metabolic disorders (1217)
Multiple sclerosis (154)
NASH (13)
Neurodegenerative disease (311)
Neuropsychiatric disorders (88)
Neuroscience (2830)
Neurotech (1)
NextGen: Class of 2026 (6406)
Non-profit (4372)
Now hiring (21)
Obesity (554)
Opinion (296)
Ovarian cancer (162)
Pain (203)
Pancreatic cancer (229)
Parkinson's disease (279)
Partnered (33)
Patents (513)
Patient recruitment (518)
Peanut (59)
People (61409)
Pharmaceutical (19)
Pharmacy benefit managers (27)
Phase 1 (20909)
Phase 2 (29247)
Phase 3 (21339)
Pipeline (5343)
Policy (284)
Postmarket research (2487)
Preclinical (8881)
Press Release (67)
Prostate cancer (248)
Psychedelics (42)
Radiopharmaceuticals (282)
Rare diseases (842)
Real estate (6055)
Recruiting (66)
Regulatory (22490)
Reports (41)
Research institute (2480)
Resumes & cover letters (408)
Rett syndrome (28)
RNA editing (15)
RSV (72)
Schizophrenia (147)
Series A (243)
Series B (185)
Service/supplier (8)
Sickle cell disease (95)
Special edition (16)
Spinal muscular atrophy (155)
Sponsored (43)
Startups (3389)
State (1)
Stomach cancer (12)
Supply chain (87)
Tariffs (67)
The Weekly (60)
Vaccines (985)
Venture capital (79)
Weight loss (340)
Women's health (87)
Worklife (21)
Date
Today (159)
Last 7 days (653)
Last 30 days (2248)
Last 365 days (28457)
2026 (3972)
2025 (28738)
2024 (32359)
2023 (36445)
2022 (46741)
2021 (51698)
2020 (50836)
2019 (44928)
2018 (34175)
2017 (30802)
2016 (30173)
2015 (35584)
2014 (28545)
2013 (25097)
2012 (26381)
2011 (26623)
2010 (25106)
Location
Africa (891)
Alabama (86)
Alaska (6)
Arizona (244)
Arkansas (15)
Asia (39508)
Australia (7087)
California (10480)
Canada (3184)
China (1064)
Colorado (443)
Connecticut (448)
Delaware (332)
Europe (92501)
Florida (1586)
Georgia (352)
Hawaii (3)
Idaho (59)
Illinois (881)
India (68)
Indiana (483)
Iowa (22)
Japan (417)
Kansas (119)
Kentucky (39)
Louisiana (26)
Maine (75)
Maryland (1291)
Massachusetts (7386)
Michigan (336)
Minnesota (564)
Mississippi (6)
Missouri (138)
Montana (34)
Nebraska (26)
Nevada (114)
New Hampshire (77)
New Jersey (2911)
New Mexico (30)
New York (2853)
North Carolina (1422)
North Dakota (10)
Northern California (5067)
Ohio (324)
Oklahoma (23)
Oregon (42)
Pennsylvania (2078)
Puerto Rico (24)
Rhode Island (45)
South America (1190)
South Carolina (54)
South Dakota (1)
Southern California (4171)
Tennessee (170)
Texas (1670)
United States (37613)
Utah (326)
Vermont (1)
Virginia (260)
Washington D.C. (67)
Washington State (867)
West Virginia (4)
Wisconsin (125)
Wyoming (2)
670,399 Results for "university of british columbia".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Rezurock® now reimbursed in Ontario and British Columbia for people living with chronic graft-versus-host disease (GVHD)
February 3, 2026
·
4 min read
Press Releases
British Columbia reimburses FRUZAQLATM (fruquintinib capsules) for the treatment of metastatic colorectal cancer (mCRC)
December 17, 2025
·
5 min read
Press Releases
Alloy Therapeutics and University of British Columbia Partner to Accelerate Antibody Discovery with Cryo-Electron Microscopy Technology
October 8, 2025
·
3 min read
Press Releases
Arch Biopartners Expands Phase II Cardiac Surgery-Associated AKI Trial to Include Royal Columbian Hospital in British Columbia
November 6, 2025
·
5 min read
Press Releases
Rakovina Therapeutics Highlights Long-Standing Collaboration with the University of British Columbia and the Vancouver Prostate Centre
July 30, 2025
·
4 min read
Press Releases
Pfizer’s PREVNAR 20 Selected for Pneumococcal Public Immunization Program in British Columbia
September 10, 2025
·
4 min read
Press Releases
BIOQuébec and Life Sciences British Columbia Announce Strategic Collaboration to Strengthen Canada’s Life Sciences Sector
May 29, 2025
·
2 min read
Press Releases
Medexus and British Columbia’s Provincial Health Services Authority (PHSA) Successfully Complete Agreement for Public Reimbursement of Trecondyv (treosulfan for injection) in British Columbia, Canada
January 15, 2025
·
8 min read
Policy
PreveCeutical Commences Litigation Against Former Legal Counsel in the British Columbia Supreme Court Alleging Professional Negligence
PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the “Company” or “PreveCeutical”), announces that it, along with certain others, filed a Notice of Civil Claim (the “Claim”) in the British Columbia Supreme Court on June 5, 2024 against its former legal counsel (the “Defendants”).
June 6, 2024
·
5 min read
Press Releases
Quince Therapeutics Presents Safety Data from Long-Term eDSP Treatment in Children with Ataxia-Telangiectasia at British Paediatric Neurology Association Annual Meeting
January 29, 2026
·
5 min read
1 of 67,040
Next
